A detailed history of Radnor Capital Management, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Radnor Capital Management, LLC holds 23,784 shares of EW stock, worth $1.61 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
23,784
Previous 5,184 358.8%
Holding current value
$1.61 Million
Previous $479,000 227.77%
% of portfolio
0.23%
Previous 0.15%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$59.7 - $93.78 $1.11 Million - $1.74 Million
18,600 Added 358.8%
23,784 $1.57 Million
Q4 2023

Jan 11, 2024

SELL
$61.71 - $77.76 $37,026 - $46,656
-600 Reduced 10.37%
5,184 $395,000
Q2 2023

Jul 07, 2023

BUY
$81.41 - $94.33 $470,875 - $545,604
5,784 New
5,784 $546,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Radnor Capital Management, LLC Portfolio

Follow Radnor Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Radnor Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Radnor Capital Management, LLC with notifications on news.